All News

The chairman of the board of Memorial Sloan Kettering Cancer Center (MSKCC) told the hospital’s staff that the former chief medical officer, José Baselga, MD, had “crossed lines” and had gone “off the reservation” in his outside dealings with health and drug companies; more than any other industry, the pharmaceutical industry benefits from a patent strategy that allows small changes in existing drugs to confer continued patent protection; public health officials are worried that the latest Ebola outbreak in the Democratic Republic of the Congo may be spinning beyond their control and could spill over into Uganda and Rwanda.

A single leukemia cell was able to reproduce and cause a deadly relapse of pediatric B-cell acute lymphoblastic leukemia (ALL) after it had bonded with the leukemia-targeting chimeric antigen receptor (CAR) lentivirus and infused back into a patient. The case of the cell that became resistant to CAR T-cell therapy was published in the journal Nature Medicine Monday.

Senators Orrin Hatch, R-Utah, and Michael Bennet, D-Colorado, have introduced a new bill that would allow the FDA to include off-label uses on certain generic drug labels; in the 2017-2018 flu season, influenza killed 80,000 Americans, easily surpassing the previous record of 56,000 deaths for a regular flu season; in the last 4 years, the number of babies born with syphilis has more than doubled, reaching a 20-year high.

Earlier this week, 3 studies were released that investigated the financial difficulties seen in patients living with cancer. Such difficulties are referred to as “financial toxicity,” which was studied in patients with metastatic breast cancer and older patients, as well as the conversations about cost of care that women with breast cancer have with their physicians.

Patients with chronic obstructive pulmonary disease (COPD) often have a significant disease burden that is particularly associated with the peak incidence of exacerbation events during winter months. A review assessed previous population studies that evaluated the impact of seasonality in COPD, emphasizing the importance of understanding how all factors impact patients and where interventions can be targeted.

This week, the top managed care news included comments to several proposals from CMS; Medicare advocates say voters will be motivated by healthcare cost concerns during the midterm elections; research showed diabetes drug dapagliflozin, an SGLT2 inhibitor, reduces risks of major cardiovascular events.

Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo